Provided by Tiger Trade Technology Pte. Ltd.

BETTERLIFE PHARMA INC.

0.0384
-0.0017-4.24%
Volume:3.04K
Turnover:121.62
Market Cap:5.83M
PE:-4.04
High:0.0430
Open:0.0430
Low:0.0384
Close:0.0401
52wk High:0.0920
52wk Low:0.0276
Shares:151.90M
Float Shares:109.91M
Volume Ratio:0.10
T/O Rate:0.00%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.0095
ROE:-4416.54%
ROA:-445.30%
PB:-0.84
PE(LYR):- -

Loading ...

Company Profile

Company Name:
BETTERLIFE PHARMA INC.
Exchange:
OTCQB
Establishment Date:
2002
Employees:
7
Office Location:
1275 West 6th Avenue,Suite 300,Vancouver,British Columbia,Canada
Zip Code:
V6H 1A6
Phone:
- -
Fax:
604 805 7783
Introduction:
BetterLife Pharma Inc., a biotechnology company, engages in the development and commercialization of compounds for the treatment of mental disorders in Canada. It is also involved in refining and developing drug candidates from a set of complementary interferon-based technologies that have the potential to engage the immune system to fight virus infections. The company's products pipeline includes BETR-001 for the treatment of major depressive disorder, anxiety, and neuropathic pain and other neuro-psychiatric and neurological disorders; and BETR-002 to treat benzodiazepine dependency, anxiety, and neurodegenerative disorders. It is also developing MM-003, which has completed Phase II clinical trials for treatment of COVID-19 and other respiratory viral infections; and MM-001, a topical cream for local intravaginal use to treat HPV-induced cervical intraepithelial neoplasia that has completed Phase II clinical trials. The company was formerly known as Pivot Pharmaceuticals Inc. and changed its name to BetterLife Pharma Inc. in December 2019. BetterLife Pharma Inc. was incorporated in 2002 and is headquartered in Vancouver, Canada.